Profile
Yu Hong Geng served as a Member-Supervisory Board at BIOTON SA. Later, from 2014 to 2021, Geng worked as a Vice President at Shanghai United Cell Biotechnology Co. Ltd.
Geng holds a doctorate degree from the University of Hong Kong, which was conferred in 2002.
Additionally, Geng holds a graduate degree from Fudan University, which was conferred in 1996.
Former positions of Yu Hong Geng
| Companies | Position | End |
|---|---|---|
Shanghai United Cell Biotechnology Co. Ltd.
 Shanghai United Cell Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of United Laboratories, Inc., Shanghai United Cell Biotechnology Co. Ltd. is an industrialized base that integrates the research and development, manufacturing, and sales of genetic reorganization biological products and vaccines. The company is based in Shanghai, China. The Chinese company has always adhered to the principle of developing high-quality drugs and vaccine products through innovation to better serve society and benefit humanity. The company's products include injection reorganization typa peptide reorganization B sub-sub-unit/bacterial cholera vaccine, injection of employment growth hormone in employment hormone. | Chief Tech/Sci/R&D Officer | 2014-06-30 |
| BIOTON S.A. | Director/Board Member | - |
Training of Yu Hong Geng
| University of Hong Kong | Doctorate Degree |
| Fudan University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOTON S.A. | Health Technology |
| Private companies | 1 |
|---|---|
Shanghai United Cell Biotechnology Co. Ltd.
Shanghai United Cell Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of United Laboratories, Inc., Shanghai United Cell Biotechnology Co. Ltd. is an industrialized base that integrates the research and development, manufacturing, and sales of genetic reorganization biological products and vaccines. The company is based in Shanghai, China. The Chinese company has always adhered to the principle of developing high-quality drugs and vaccine products through innovation to better serve society and benefit humanity. The company's products include injection reorganization typa peptide reorganization B sub-sub-unit/bacterial cholera vaccine, injection of employment growth hormone in employment hormone. | Health Technology |
- Stock Market
- Insiders
- Yu Hong Geng
